---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-016655"
form_type: "8-K"
ticker: "SONM"
cik: "0001178697"
company_name: "DNA X, Inc."
filed_at: "2026-04-15T23:59:59+00:00"
generated_at: "2026-05-15T06:01:08.845335+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# DNA X reports FY2025 no revenue from continuing ops; closes mobile asset sale for $15M

## Summary
- No revenue from continuing operations in Q4 2025; G&A expenses $1.2M primarily for acquisition and sale costs.
- Completed sale of mobile device assets to NEXA Mobility on Jan 23, 2026 for $15M; $13.5M paid immediately.
- CEO and board member resigned Jan 30, 2026; Executive Chairman Mike Mulica named acting CEO; Scott Walker appointed to board.
- Cash from continuing ops $1.3M at Dec 31, 2025; proceeds used to repay debt and support DNA X crypto platform.
- Rebranded as DNA X, Inc. from Sonim Technologies; Nasdaq ticker remains SONM.

## SEC filing metadata
- accession: 0001493152-26-016655
- form_type: 8-K
- ticker: SONM
- cik: 0001178697
- company_name: DNA X, Inc.
- filed_at: 2026-04-15T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1178697/000149315226016655/0001493152-26-016655-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1178697/000149315226016655/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-016655
- JSON: https://secwatch.observer/filing/0001493152-26-016655.json
- Plain text: https://secwatch.observer/filing/0001493152-26-016655.txt

## Source-grounded claims
- claim_id: 51551a7095b1783034c8497918959313c70b08c4
  claim: DNA X, Inc. reported the fourth quarter and full year ended December 31, 2025 results: revenue There was no revenue from continuing operations.
  evidence_excerpt: On April 14, 2026, DNA X, Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended December 31, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/1178697/000149315226016655/0001493152-26-016655-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.